BSECaprolactam Chemicals LtdMinimalNeutral
Announced Mon, 1 Jun · 14:24 IST

Newspaper Advertisement of the Audited Financial Result for Quarter ended 31 March 2026

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-3.1%1-day move
₹49.00
prior close
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-3.1+0.0-1.1+0.0+0.0-5.7
Up moveDown movePending
AI summary

Caprolactam Chemicals Ltd has submitted to BSE copies of newspaper advertisements of its audited financial results for Q4 and FY ended 31 March 2026, published in Financial Express (English) and Mumbai Lakshdeep (Marathi) on 31 May 2026. For FY26, total income from operations rose to ₹1,058.88 lakhs from ₹674.52 lakhs in FY25, while net profit after tax swung to a profit of ₹175.28 lakhs from a loss of ₹71.83 lakhs in the previous year. For Q4 FY26 alone, the company reported total income of ₹307.40 lakhs and net profit after tax of ₹82.83 lakhs. Basic and diluted EPS for FY26 stood at ₹3.83, compared to a negative figure implied by the prior-year loss. The results were approved by the Board on 30 May 2026 and reviewed by the statutory auditors.

Likely market impact

The company has returned to profitability with a sharp recovery in both revenue and bottom line compared to FY25, which is a positive signal for shareholders. This filing itself is procedural — the underlying results had already been approved and would have been filed separately.